Viewing StudyNCT01794299



Ignite Creation Date: 2024-05-06 @ 1:23 AM
Last Modification Date: 2024-10-26 @ 11:03 AM
Study NCT ID: NCT01794299
Status: COMPLETED
Last Update Posted: 2021-04-12
First Post: 2013-02-14

Brief Title: Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells ATIR in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
Sponsor: Kiadis Pharma
Organization: Kiadis Pharma

Conditions & Keywords Data

Conditions:
Name
Myelodysplastic Syndrome
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Keywords:
Name View
Haploidentical stem cell transplantation View
Graft-versus-host disease View
Immune reconstitution View
Alloreactive T-cells View
Photodepletion View
Photodynamic treatment View
TH9402 View
Transplant-related mortality View
Hematologic malignancy View